Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF). [electronic resource]
Producer: 20150320Description: 113-20 p. digitalISSN:- 2190-393X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.